Cargando…
Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence
Breast cancer is the leading new cancer diagnosis in women in the United States and is the second most lethal cancer in this patient population after lung cancer. Chest wall recurrence after mastectomy poses unique clinical challenges, as such tumors are often not amenable to surgical resection and...
Autores principales: | Dyer, Brandon A, Nguyen, Ky Nam B, Shukla, Rakendu P, Li, Tianhong, Daly, Megan E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522017/ https://www.ncbi.nlm.nih.gov/pubmed/28775919 http://dx.doi.org/10.7759/cureus.1379 |
Ejemplares similares
-
Concurrent Chemoradiation for Vaginal Cancer
por: Miyamoto, David T., et al.
Publicado: (2013) -
Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
por: Vreugdenhil, M., et al.
Publicado: (2021) -
A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy
por: Yamada, Kaori, et al.
Publicado: (2018) -
Massive chest wall resection and reconstruction for malignant disease
por: Foroulis, Christophoros N, et al.
Publicado: (2016) -
Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
por: Kim, Nalee, et al.
Publicado: (2023)